A Detailed Analysis of the Low and Middle Income Countries Opioid Substitution Therapy Market Based on the Consistently Rising Drug-dependent Population, and Rising Prevalence of Opioid Use Disorder
Industry: Healthcare
Published Date: November--0001
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 200
Report ID: PMRREP33745
1. Executive Summary
1.1. Global Low and Middle Income Countries Opioid Substitution Therapy Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Drug Class Lifecycle Analysis
2.4. Low and Middle Income Countries Opioid Substitution Therapy Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Drug Class
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Drug Class, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
3.3.3.1. Opioid Antagonists
3.3.3.2. Naloxone
3.3.3.3. Naltrexone
3.3.3.4. Opioid Agonists and Partial Agonists
3.3.3.5. Methadone
3.3.3.6. Buprenorphine
3.4. Market Attractiveness Analysis: Drug Class
3.5. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Indication
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Indication, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
3.5.3.1. Pain Management
3.5.3.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
3.5.3.3. Alcohol De-addiction
3.5.3.4. Depression
3.6. Market Attractiveness Analysis: Indication
3.7. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Distribution Channel
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution Channel, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
3.7.3.1. Government-supported Centers/NGO's/Tenders
3.7.3.2. Institutional Sales
3.7.3.3. Hospitals
3.7.3.4. Psychiatric clinics
3.7.3.5. Retail Pharmacies
3.7.3.6. Online Sales
3.8. Market Attractiveness Analysis: Distribution Channel
4. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia & Pacific
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Drug Class
5.3.3. By Indication
5.3.4. By Distribution Channel
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
5.5.1. Opioid Antagonists
5.5.2. Naloxone
5.5.3. Naltrexone
5.5.4. Opioid Agonists and Partial Agonists
5.5.5. Methadone
5.5.6. Buprenorphine
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
5.6.1. Pain Management
5.6.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
5.6.3. Alcohol De-addiction
5.6.4. Depression
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
5.7.1. Government-supported Centers/NGO's/Tenders
5.7.2. Institutional sales
5.7.3. Hospitals
5.7.4. Psychiatric clinics
5.7.5. Retail Pharmacies
5.7.6. Online Sales
5.8. Market Attractiveness Analysis
6. Europe Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Drug Class
6.3.3. By Indication
6.3.4. By Distribution Channel
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkey
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
6.5.1. Opioid Antagonists
6.5.2. Naloxone
6.5.3. Naltrexone
6.5.4. Opioid Agonists and Partial Agonists
6.5.5. Methadone
6.5.6. Buprenorphine
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
6.6.1. Pain Management
6.6.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
6.6.3. Alcohol De-addiction
6.6.4. Depression
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
6.7.1. Government-supported Centers/NGO's/Tenders
6.7.2. Institutional sales
6.7.3. Hospitals
6.7.4. Psychiatric clinics
6.7.5. Retail Pharmacies
6.7.6. Online Sales
6.8. Market Attractiveness Analysis
7. East Asia Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Drug Class
7.3.3. By Indication
7.3.4. By Distribution Channel
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
7.5.1. Opioid Antagonists
7.5.2. Naloxone
7.5.3. Naltrexone
7.5.4. Opioid Agonists and Partial Agonists
7.5.5. Methadone
7.5.6. Buprenorphine
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
7.6.1. Pain Management
7.6.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
7.6.3. Alcohol De-addiction
7.6.4. Depression
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
7.7.1. Government-supported Centers/NGO's/Tenders
7.7.2. Institutional sales
7.7.3. Hospitals
7.7.4. Psychiatric clinics
7.7.5. Retail Pharmacies
7.7.6. Online Sales
7.8. Market Attractiveness Analysis
8. South Asia & Oceania Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Drug Class
8.3.3. By Indication
8.3.4. By Distribution Channel
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
8.5.1. Opioid Antagonists
8.5.2. Naloxone
8.5.3. Naltrexone
8.5.4. Opioid Agonists and Partial Agonists
8.5.5. Methadone
8.5.6. Buprenorphine
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
8.6.1. Pain Management
8.6.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
8.6.3. Alcohol De-addiction
8.6.4. Depression
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
8.7.1. Government-supported Centers/NGO's/Tenders
8.7.2. Institutional sales
8.7.3. Hospitals
8.7.4. Psychiatric clinics
8.7.5. Retail Pharmacies
8.7.6. Online Sales
8.8. Market Attractiveness Analysis
9. Latin America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Drug Class
9.3.3. By Indication
9.3.4. By Distribution Channel
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
9.5.1. Opioid Antagonists
9.5.2. Naloxone
9.5.3. Naltrexone
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
9.6.1. Pain Management
9.6.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
9.6.3. Alcohol De-addiction
9.6.4. Depression
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
9.7.1. Government-supported Centers/NGO's/Tenders
9.7.2. Institutional sales
9.7.3. Hospitals
9.7.4. Psychiatric clinics
9.7.5. Retail Pharmacies
9.7.6. Online Sales
9.8. Market Attractiveness Analysis
10. Middle East & Africa Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Drug Class
10.3.3. By Indication
10.3.4. By Distribution Channel
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
10.5.1. Opioid Antagonists
10.5.2. Naloxone
10.5.3. Naltrexone
10.5.4. Opioid Agonists and Partial Agonists
10.5.5. Methadone
10.5.6. Buprenorphine
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
10.6.1. Pain Management
10.6.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
10.6.3. Alcohol De-addiction
10.6.4. Depression
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
10.7.1. Government-supported Centers/NGO's/Tenders
10.7.2. Institutional sales
10.7.3. Hospitals
10.7.4. Psychiatric clinics
10.7.5. Retail Pharmacies
10.7.6. Online Sales
10.8. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Indivior Inc.
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Alkermes, Inc
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Mundipharma GmbH
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Viatris Inc
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Intas Pharmaceuticals
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Camurus
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
